Skip to main content
Publications
Ling W, Nadipelli VR, Aldridge AP, Ronquest NA, Solem CT, Chilcoat H, Albright V, Johnson C, Learned SM, Mehra V, Heidbreder C. Recovery from Opioid Use Disorder (OUD) after monthly long-acting buprenorphine treatment: 12-month longitudinal outcomes from RECOVER, an observational study. J Addict Med. 2020 Sep;14(5):e233-40. doi: 10.1097/ADM.0000000000000647
Ling W, Nadipelli VR, Solem CT, Ronquest NA, Yeh YC, Learned SM, Mehra V, Heidbreder C. Patient-centered outcomes in participants of a buprenorphine monthly depot (BUP-XR) double-blind, placebo-controlled, multicenter, phase 3 study. J Addict Med. 2019 Nov;13(6):442-9. doi: 10.1097/ADM.0000000000000517.
Morelli X, Foraster M, Aguilera I, Basagana X, Corradi E, Deltell A, Ducret-Stich R, Phuleria H, Ragettli MS, Rivera M, Thomasson A, Kunzli N, Slama R. Short-term associations between traffic-related noise, particle number and traffic flow in three European citie. Atmos Environ. 2015 Feb;103:25-33. doi: 10.1016/j.atmosenv.2014.12.012
Ragettli MS, Ducret-Stich RE, Foraster M, Morelli X, Aguilera I, Basagana X, Corradi E, Ineichen A, Tsai M, Probst-Hensch N, Rivera M, Slama R, Kunzli N, Phuleria HC. Spatio-temporal variation of urban ultrafine particle number concentrations. Atmos Environ. 2014 Oct;96:275-83. doi: 10.1016/j.atmosenv.2014.07.049
Bui CL, Kaye JA, Castellsague J, Calingaert B, McQuay LJ, Riera-Guardia N, Saltus CW, Quinlan SC, Holick CN, Wahl PM, Suzart K, Rothman KJ, Wallander MA, Perez-Gutthann S. Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial users. Curr Drug Saf. 2014 Mar;9(1):23-8.
Basagana X, Rivera M, Aguilera I, Agis D, Bouso L, Elosua R, Foraster M, de Nazelle A, Nieuwenhuijsen M, Vila J, Kunzli N. Effect of the number of measurement sites on land use regression models in estimating local air pollution. Atmos Environ. 2012 Jul;54:634-42. doi: 10.1016/j.atmosenv.2012.01.064